ACHEIVING BIOAVAILABILITY 

99.8%

The Worlds First Supplements to Deliver Potent Bioactive Direct to Target Cells Without Typical Degradation 

5.0
MICROSPHERE™ ENCAPSULATED INGREDIENT DELIVERY

THE ABSORPTION ISSUE

The supplement industry faces a significant yet ignored issue: poor bioavailability.

This issue impacts all oral supplements, from metabolism enhancers to testosterone boosters, and affects virtually all compounds, including testosterone itself.

DIGESTIVE DEGRADATION

The Core Issue: The "First Pass Effect"

The challenge originates from the "first pass effect." Oral supplements must pass through the liver and digestive system before reaching the bloodstream, a process that significantly degrades many active compounds. A staggering amount, often as little as 0.6% of the intended dose actually reaches its target, leading to reduced efficacy and unnecessary waste.

5.1

Clinically effective Dose vs. Real-World Dose

The unrealized potential of some of the industry's most common ingredients and otherwise highly promising compounds is rendered useless due to significant gaps between the doses used in clinical trials and those received in the real world.

BIOAVAILABILITY BREAKDOWN

* Bioavailability 
5.2

Past Solutions and Their Shortcomings

Several methods have been explored to overcome the challenge of poor bioavailability. While injections undeniably offer a direct route, ensuring 100% bioavailability, they introduce discomfort and inconvenience for the user.

The development of synthetic compound analogs aimed to enhance resistance to liver degradation - However, these often fall short of replicating the full spectrum of natural compound benefits and can pose toxicity risks. Other delivery methods like transdermal creams, gels, and sprays provide partial improvements but face challenges in practical application and effectiveness.

BIOAVAILABILITY BREAKDOWN

003

Introducing Future Pharma's MicroSphere™ Technology

Future Pharmaceuticals unveils a groundbreaking solution: MicroSphere™ Technology. This revolutionary approach to oral bioactive ingredient delivery leverages advanced nanoparticle technology. By encapsulating bioactive molecules within a microscopic protective layer, it shields them from gastric degradation. This 'Trojan Horse' method ensures seamless passage through the digestive system, preserving the integrity of the compounds for optimal bioavailability.

004

INGREDIENTS CONTAINED WITHIN
MICROSCOPTIC CAPSULES >

Delivering Bioactive Payloads Directly to Target Cells

Unlike standard ingredients, Microsphere™ Technology guarantees that potent yet delicate compounds reach systemic circulation intact. By bypassing inactivation, these compounds directly target tissues—such as muscle myocytes, adipocytes, or neuronal brain cells—where they can activate key cellular pathways critical for performance.

004

Achieving 99%+ Bioavailability

Nanoparticle technology, initially pioneered by the pharmaceutical industry, is now revolutionizing the performance enhancement sector. For the first time, Future Pharmas encapsulation technology enables poorly absorbed performance-enhancing molecules to realize their full potential, heralding a new era in bioactive potency.

99.8%  vs  0-5%

004

UNLEASHING A New Era of bioactive molecules

Future Pharmaceuticals is revolutionizing the supplement industry by tapping into the potential of potent, yet previously underutilized, ingredients. Our research is focusing on compounds like Colostrum, which activates IGF-1 pathways but is typically inactive in adult digestion, and Chrysin, known for boosting testosterone DAX pathways effectively—though traditionally only when injected directly into the testicles. Our advanced technology now makes these ingredients both usable and effective when consumed orally, heralding a new era in supplement efficacy.

APIGENIN -  sTAR PATHWAY

004